FR2737135B1 - Gels inverses a phase continue fluoree - Google Patents

Gels inverses a phase continue fluoree

Info

Publication number
FR2737135B1
FR2737135B1 FR9508965A FR9508965A FR2737135B1 FR 2737135 B1 FR2737135 B1 FR 2737135B1 FR 9508965 A FR9508965 A FR 9508965A FR 9508965 A FR9508965 A FR 9508965A FR 2737135 B1 FR2737135 B1 FR 2737135B1
Authority
FR
France
Prior art keywords
fluorinated
continuous phase
phase reverse
organic compound
nonfluorinated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9508965A
Other languages
English (en)
Other versions
FR2737135A1 (fr
Inventor
Marie Pierre Krafft
Jean G Riess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ATTA
Original Assignee
ATTA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9508965A priority Critical patent/FR2737135B1/fr
Application filed by ATTA filed Critical ATTA
Priority to AT96925440T priority patent/ATE227558T1/de
Priority to EP96925440A priority patent/EP0841896B1/fr
Priority to PCT/US1996/012138 priority patent/WO1997003644A1/fr
Priority to DE69624820T priority patent/DE69624820D1/de
Priority to AU65953/96A priority patent/AU717321B2/en
Priority to CA002227744A priority patent/CA2227744A1/fr
Priority to JP9506959A priority patent/JPH11509843A/ja
Publication of FR2737135A1 publication Critical patent/FR2737135A1/fr
Application granted granted Critical
Publication of FR2737135B1 publication Critical patent/FR2737135B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
FR9508965A 1995-07-24 1995-07-24 Gels inverses a phase continue fluoree Expired - Fee Related FR2737135B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9508965A FR2737135B1 (fr) 1995-07-24 1995-07-24 Gels inverses a phase continue fluoree
EP96925440A EP0841896B1 (fr) 1995-07-24 1996-07-24 Gels inverses comprenant une phase fluoree continue
PCT/US1996/012138 WO1997003644A1 (fr) 1995-07-24 1996-07-24 Gels inverses comprenant une phase fluoree continue
DE69624820T DE69624820D1 (de) 1995-07-24 1996-07-24 Umkehrgele mit einer kontinuierlichen fluorierten phase
AT96925440T ATE227558T1 (de) 1995-07-24 1996-07-24 Umkehrgele mit einer kontinuierlichen fluorierten phase
AU65953/96A AU717321B2 (en) 1995-07-24 1996-07-24 Reverse gels comprising a continuous fluorinated phase
CA002227744A CA2227744A1 (fr) 1995-07-24 1996-07-24 Gels inverses comprenant une phase fluoree continue
JP9506959A JPH11509843A (ja) 1995-07-24 1996-07-24 連続フッ素化相からなるリバースゲル

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9508965A FR2737135B1 (fr) 1995-07-24 1995-07-24 Gels inverses a phase continue fluoree

Publications (2)

Publication Number Publication Date
FR2737135A1 FR2737135A1 (fr) 1997-01-31
FR2737135B1 true FR2737135B1 (fr) 1997-09-12

Family

ID=9481315

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9508965A Expired - Fee Related FR2737135B1 (fr) 1995-07-24 1995-07-24 Gels inverses a phase continue fluoree

Country Status (8)

Country Link
EP (1) EP0841896B1 (fr)
JP (1) JPH11509843A (fr)
AT (1) ATE227558T1 (fr)
AU (1) AU717321B2 (fr)
CA (1) CA2227744A1 (fr)
DE (1) DE69624820D1 (fr)
FR (1) FR2737135B1 (fr)
WO (1) WO1997003644A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2314020B (en) * 1996-06-13 2000-12-20 Secr Defence Use of perfluoro compounds in a topical barrier cream
US6023607A (en) * 1997-05-30 2000-02-08 Nokia Telecommunication Oy Radio system and a call setup method
DE19926889B4 (de) 1999-06-12 2005-06-16 Bausch & Lomb Inc. Verwendung eines Gels mit Polyaphronstruktur zur Herstellung eines Implantats
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
DE60134657D1 (de) 2000-09-26 2008-08-14 Univ North Carolina Phosphat-fluortenside zur verwendung in kohlendioxid
WO2019017295A1 (fr) * 2017-07-21 2019-01-24 株式会社ダイセル Composition gélifiée
JP6952305B2 (ja) * 2017-11-13 2021-10-20 株式会社サナス 糖脂肪酸エステルおよびオイルゲル化剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2679150A1 (fr) * 1991-07-17 1993-01-22 Atta Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
FR2720943B1 (fr) * 1994-06-09 1996-08-23 Applic Transferts Technolo Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.

Also Published As

Publication number Publication date
ATE227558T1 (de) 2002-11-15
EP0841896A1 (fr) 1998-05-20
AU717321B2 (en) 2000-03-23
WO1997003644A1 (fr) 1997-02-06
AU6595396A (en) 1997-02-18
EP0841896B1 (fr) 2002-11-13
FR2737135A1 (fr) 1997-01-31
DE69624820D1 (de) 2002-12-19
JPH11509843A (ja) 1999-08-31
CA2227744A1 (fr) 1997-02-06

Similar Documents

Publication Publication Date Title
ATE402712T1 (de) Synergistische antimikrobielle ophthalmische zubereitungen mit chlorit- und wasserstoffperoxid
DK0722313T3 (da) Viskoelastiske sammensætninger af fluorerede organiske forbindelser
MA27520A1 (fr) Composition pharmaceutique
UY24246A1 (es) Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
BR0112461A (pt) Composições que contém componentes terapeuticamente ativos tendo uma solubilidade aumentada
ATE254928T1 (de) Stabilisierte zusammensetzung mit nootropen wirkstoffen
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
CA2166480A1 (fr) Desinfectant possedant une duree de vie active prolongee
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ATE166534T1 (de) Germicide wirkstoffkombinationen
ATE254478T1 (de) Stabile zusammensetzungen enthaltend ein retinoid und ein antioxidierendes system auf enzymbasis
FR2737135B1 (fr) Gels inverses a phase continue fluoree
ATE284996T1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
PE20001244A1 (es) Formulaciones antiparasitos que contienen doramectina
ES2121109T3 (es) Composicion de champu.
ES2146417T3 (es) Agente para el fregado de la vajilla.
NO20013499D0 (no) Farmasöytisk blanding omfattende en kombinasjon av en profen og andre aktive forbindelser
BRPI0309768B8 (pt) composição lubrificante substancialmente anidra
ES2156763A1 (es) Formulacion estables de solucion de apomorfina.
DK0699030T3 (da) Mikrobicide midler
AR030087A1 (es) Una composicion oral
TR200000890T2 (tr) Topik ilacın üretilmesi için -amino levülozik asidin kullanılması
AR013749A1 (es) Tratamiento de retinopatia diabetica
NO20041508L (no) Rengjoringspreparat.
SU1637807A1 (ru) Средство дл индивидуальной профилактики венерических заболеваний у мужчин

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse